Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
IntroductionAdministering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality.The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or IHD, treat...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Touch Medical Media
2017-10-01
|
Series: | Heart International |
Online Access: | http://www.heart-int.com/Attach/84719789-A605-4F3E-8D83-E97AFFA73B2F/F215CEC2-F07E-4C07-BCE0-9DA2B5CDD2FF |
id |
doaj-c864068aa8fa4688aff98381bf599887 |
---|---|
record_format |
Article |
spelling |
doaj-c864068aa8fa4688aff98381bf5998872020-11-24T20:59:26ZengTouch Medical MediaHeart International1826-18682036-25792017-10-011210010.5301/heartint.5000237Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndromeCălin PopRoberta FlorescuClaudia MateiLavinia PopViorel ManeaCoralia CotoraciLiana MosAntoniu PetrisIntroductionAdministering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality.The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or IHD, treated or untreated with OCM, who developed a first episode of acute coronary syndrome (ACS).MethodsThe study was carried out retrospectively and included patients admitted with a first episode of ACS between 2013 and 2016. The patients were divided into three groups: those with HBP, IHD, and a history of HBP + IHD. Patients were then divided into two subgroups: subgroup A consisted of patients undergoing optimal anti-ischemic and/or antihypertensive therapy, while subgroup B consisted of patients without OCM.ResultsThis analysis comprised 1096 patients. Mean age was 64.3 ± 18 years. There were 581 patients in subgroup A – 53%, and 515 patients in subgroup B – 47%. Total cardiac mortality was 9.98%, different depending on the groups and subgroups studied: HBP group total – 7%, subgroup A – 5.1%, significantly lower compared to subgroup B – 9.4% (p = 0.05); IHD group total – 12.2%, subgroup A – 9.07%, significantly lower compared to subgroup B – 15.8% (p = 0.05); HBP + IHD group total – 14.35%, subgroup A – 9.9%, significantly lower compared to subgroup B – 18.8% (p = 0.05).ConclusionsThe lack of OCM in patients with HBP and/or IHD is correlated to a significant increase in in-hospital cardiac mortality among patients who develop a first-episode ACS.http://www.heart-int.com/Attach/84719789-A605-4F3E-8D83-E97AFFA73B2F/F215CEC2-F07E-4C07-BCE0-9DA2B5CDD2FF |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Călin Pop Roberta Florescu Claudia Matei Lavinia Pop Viorel Manea Coralia Cotoraci Liana Mos Antoniu Petris |
spellingShingle |
Călin Pop Roberta Florescu Claudia Matei Lavinia Pop Viorel Manea Coralia Cotoraci Liana Mos Antoniu Petris Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome Heart International |
author_facet |
Călin Pop Roberta Florescu Claudia Matei Lavinia Pop Viorel Manea Coralia Cotoraci Liana Mos Antoniu Petris |
author_sort |
Călin Pop |
title |
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome |
title_short |
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome |
title_full |
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome |
title_fullStr |
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome |
title_full_unstemmed |
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome |
title_sort |
role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome |
publisher |
Touch Medical Media |
series |
Heart International |
issn |
1826-1868 2036-2579 |
publishDate |
2017-10-01 |
description |
IntroductionAdministering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality.The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or IHD, treated or untreated with OCM, who developed a first episode of acute coronary syndrome (ACS).MethodsThe study was carried out retrospectively and included patients admitted with a first episode of ACS between 2013 and 2016. The patients were divided into three groups: those with HBP, IHD, and a history of HBP + IHD. Patients were then divided into two subgroups: subgroup A consisted of patients undergoing optimal anti-ischemic and/or antihypertensive therapy, while subgroup B consisted of patients without OCM.ResultsThis analysis comprised 1096 patients. Mean age was 64.3 ± 18 years. There were 581 patients in subgroup A – 53%, and 515 patients in subgroup B – 47%. Total cardiac mortality was 9.98%, different depending on the groups and subgroups studied: HBP group total – 7%, subgroup A – 5.1%, significantly lower compared to subgroup B – 9.4% (p = 0.05); IHD group total – 12.2%, subgroup A – 9.07%, significantly lower compared to subgroup B – 15.8% (p = 0.05); HBP + IHD group total – 14.35%, subgroup A – 9.9%, significantly lower compared to subgroup B – 18.8% (p = 0.05).ConclusionsThe lack of OCM in patients with HBP and/or IHD is correlated to a significant increase in in-hospital cardiac mortality among patients who develop a first-episode ACS. |
url |
http://www.heart-int.com/Attach/84719789-A605-4F3E-8D83-E97AFFA73B2F/F215CEC2-F07E-4C07-BCE0-9DA2B5CDD2FF |
work_keys_str_mv |
AT calinpop roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome AT robertaflorescu roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome AT claudiamatei roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome AT laviniapop roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome AT viorelmanea roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome AT coraliacotoraci roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome AT lianamos roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome AT antoniupetris roleofoptimalmedicationgiventopatientswithhypertensionandischemicheartdiseasepriortoanacutecoronarysyndrome |
_version_ |
1716782392186765312 |